Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Market Oversight topic
No spam. Unsubscribe anytime.
Cost Transparency Board backs pre‑, post‑ and ongoing transaction review to monitor health care consolidation
Summary
The Cost Transparency Board voted July 22 to include a legislative recommendation calling for pre‑transaction, post‑transaction and ongoing health care transaction review to better assess effects on affordability, access and quality. Board members said the proposal will be refined with stakeholders and additional data work.
The Cost Transparency Board on July 22 voted to include a recommendation in its 2026 legislative report to pursue a health care transaction review program that would operate before transactions close, after transactions conclude and as part of ongoing market monitoring.
Board members framed the action as a way to bring new state oversight tools to bear on hospital, insurer and private equity activity they said has contributed to higher prices and reduced local choice. "This could become continued extension of the board's work in 2027," staff said as they described next steps for stakeholder engagement and drafting. Emily Bryce moved the motion; Elois Cook seconded it. Chair Moran announced the motion passed with no recorded opposition.
Supporters described the recommendation as a directional step that will let staff and the legislature build the details later. Emily Bryce said the recommendation is "necessary but not sufficient," urging that pre‑transaction review be paired with ongoing market analysis and other cost‑containment tools. Several members stressed the need to include a broad set of entity types in any notice requirement, not only hospitals and traditional payers.
Opponents did not register on the record during the voice vote, but board members used the discussion to press for clarifications about timing and scope. Eileen Cody urged that the language make clear the review should occur before a merger closes: "it doesn't make it clear that we would like the review prior to a merger," she said. Staff committed to return with draft language and to solicit stakeholder input before finalizing the bill language.
The board's action follows two months of briefings — including presentations from Colorado and California officials — and public comment from trade groups and physician organizations who recommended Washington tailor approaches to its own data and legal context. Staff said the recommendation will be accompanied by a white paper describing options, tradeoffs and potential statutory language for the legislature to consider.
What happens next: staff will solicit additional stakeholder input in August and present detailed concepts to the board in September, then finalize the language for the 2026 legislative report.
